Improvements in lung diffusion capacity following pulmonary rehabilitation in COPD with and without ventilation inhomogeneity

Respiration

Volumn 92, Issue 5, 2016, Pages 295-307

  Santus, Pierachille ^a   Radovanovic, Dejan ^b   Balzano, Giovanni ^b   Pecchiari, Matteo ^a   Raccanelli, Rita ^a   Sarno, Nicola ^b   Di Marco, Fabiano ^a   Jones, Paul W ^c   Carone, Mauro ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS   (Italy)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Alveolar volume; COPD; Exercise tolerance; Lung diffusing capacity; Pulmonary rehabilitation; Transfer factor; Ventilation inhomogeneity

Indexed keywords

BRONCHODILATING AGENT;

AGED; AIRFLOW; ARTICLE; BICYCLE ERGOMETRY; BODY PLETHYSMOGRAPHY; BREATHING EXERCISE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; DISEASE SEVERITY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG GAS EXCHANGE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE TRAINING; OBSERVATIONAL STUDY; OXYGEN BREATHING; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOTHERAPY; PULMONARY REHABILITATION; RELAXATION TRAINING; RESPIRATORY TRACT PARAMETERS; SELF CARE; SIX MINUTE WALK TEST; CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY CARE; SEVERITY OF ILLNESS INDEX; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; WALK TEST;

AGED; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESPIRATORY THERAPY; SEVERITY OF ILLNESS INDEX; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; WALK TEST;

EID: 84986556280     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000448847     Document Type: Article

References (51)

1. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T; ATS/ERS Pulmonary Rehabilitation Writing Committee: American Thoracic Society/European respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-1413
2. Spruit MA, Singh SJ, Garvey C, ZuWallack R, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13-e64
3. Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K. Global assessment of the COPD patient: time to look beyond FEV1?. Respir Med 2009; 103: 650-660
4. Fitting JW. Transfer factor for carbon monoxide: a glance behind the scene. Swiss Med Wkly 2004; 134: 413-418
5. Hughes JM, Pride NB. Examination of the carbon monoxide diffusing capacity (D LCO ) in relation to its KCO and VA components. Am J Respir Crit Care Med 2012; 186: 132-139
6. Teculescu DB, Stanescu DC. Total lung capacity in obstructive lung disease: comparative determination by single and multiple breath helium dilution. Bull Eur Physiopat Jwl Respir 1969; 5: 453-464
7. Wijkstra PJ, TenVergert EM, van der Mark TW, Postma DS, Van Altena R, Kraan J, Koeter GH. Relation of lung function, maximal inspiratory pressure, dyspnea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 468-472
8. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980
9. Louvaris Z, Kortianou EA, Spetsioti S, Vasilopoulou M, Nasis I, Asimakos A, Zakynthinos S, Vogiatzis I. Intensity of daily physical activity is associated with central hemodynamic and leg muscle oxygen availability in COPD. J Appl Physiol 2013; 115: 794-802
10. Neder JA, O'Donnell CD, Cory J, Langer D, Ciavaglia CE, Ling Y, Webb KA, O'Donnell DE. Ventilation distribution heterogeneity at rest as a marker of exercise impairment in mildto-Advanced COPD. COPD 2015; 12: 249-256
11. Lopes AJ, Mafort TT. Correlations between small airway function, ventilation distribution, and functional exercise capacity in COPD patients. Lung 2014; 192: 653-659
12. Mota S, Guell R, Barreiro E, Solanes I, Ramirez-Sarmiento A, Orozco-Levi M, Casan P, Gea J, Sanchis J. Clinical outcomes of expiratory muscle training in severe COPD. Respir Med 2007; 101: 516-524
13. Sahin H, Naz I, Varol Y, Aksel N, Tuksavul F, Ozsoz A. COPD patients with severe diffusion defect in carbon monoxide diffusing capacity predict a better outcome for pulmonary rehabilitation. Rev Port Pneumol 2016, Epub ahead of print
14. Guazzi M, Reina G, Tumminello G, Guazzi MD. Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure. J Appl Physiol 2004; 97: 1866-1873
15. Cerveri I, Dore R, Corsico A, Zoia MC, Pellegrino R, Brusasco V, Pozzi E. Assessment of emphysema in COPD. A functional and radiologic study. Chest 2004; 125: 1714-1718
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J Suppl 2005; 26: 948-968
17. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-522
18. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the singlebreath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-735
19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117
20. Beauchamp MK, Janaudis-Ferreira T, Goldstein RS, Brooks D. Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease-A systematic review. Chron Respir Dis 2011; 8: 129-140
21. Greulich T, Koczulla AR, Nell C, Kehr K, Vogelmeier CF, Stojanovic D, Wittmann M, Schultz K. Effect of a three-week inpatient rehabilitation program on 544 consecutive patients with very severe COPD: a retrospective analysis. Respiration 2015; 90: 287-292
22. Quanjer PH. Standardized lung function testing. Bull Eur Physiopathol Respir 1983; 19: 22-61
23. Altenburg WA, de Greef MH, ten Hacken NH, Wempe JB. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respir Med 2012; 106: 694-700
24. Takigawa N, Tada A, Soda R, Takahashi S, Kawata N, Shibayama T, Matsumoto H, Hamada N, Hirano A, Kimura G, Okada C, Endo S, Yamashita M, Date H, Takahashi K. Comprehensive pulmonary rehabilitation according to severity of COPD. Respir Med 2007; 101: 326-332
25. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R; NETT Research Group: Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-1334
26. Crisafulli E, Venturelli E, Biscione G, Vagheggini G, Iattoni A, Lucic S, Ambrosino N, Pasqua F, Cesario A, Clini EM. Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation. Intern Emerg Med 2014; 9: 23-31
27. van Ranst D, Otten H, Meijer JW, van t Hul AJ. Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status. Int J Chron Obstruct Pulmon Dis 2011; 6: 647-657
28. Vagaggini B, Costa F, Antonelli S, De Simone C, De Cusatis G, Martino F, Santerini S, Paggiaro P. Clinical predictors of the efficacy of a pulmonary rehabilitation program in patients with COPD. Respir Med 2009; 103: 1224-1230
29. Albuquerque AL, Quaranta M, Chakrabarti B, Aliverti A, Calverley PM. Exercise performance and differences in physiological response to pulmonary rehabilitation in severe chronic obstructive pulmonary disease with hyperinflation. J Bras Pneumol 2016; 42: 121-129
30. Dubois P, Machiels J, Smeets F, Delwiche JP, Lulling J. CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-Term oxygen therapy. Eur Respir J 1990; 3: 1042-1047
31. Diaz AA, Pinto-Plata V, Hernandez C, Pena J, Ramos C, Diaz JC, Klaassen J, Patino CM, Saldias F, Diaz O. Emphysema and D LCO predict a clinically important difference for 6MWD decline in COPD. Respir Med 2015; 109: 882-889
32. Santus P, Bassi L, Radovanovic D, Airoldi A, Raccanelli R, Triscari F, Giovannelli F, Spanevello A. Pulmonary rehabilitation in COPD: a reappraisal (2008-2012). Pulm Med 2013; 2013: 374283
33. Gennimata SA, Palamidas A, Karakontaki F, Kosmas EN, Koutsoukou A, Loukides S, Koulouris NG. Pathophysiology of evolution of small airways disease to overt COPD. COPD 2010; 7: 269-275
34. Milic-Emili J, Pecchiari M, D'Angelo E. Pathophysiology of chronic obstructive pulmonary disease. Curr Resp Med Rev 2008; 4: 249-256
35. Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology Eur Respir J 2005; 25: 186-199
36. Macklem PT. Therapeutic implications of the pathophysiology of COPD. Eur Respir J 2010; 35: 676-680
37. Onodera A, Yazaki K. Effects of a short-Term pulmonary rehabilitation program on patients with chronic respiratory failure due to pulmonary emphysema. Nihon Kokyuki Gakkai Zasshi 1998; 36: 679-683
38. Baldi S, Fracchia C, Bruschi C, Dore R, Maestri R, Brusasco V, Pellegrino R. Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease. Int J COPD 2006; 1: 477-483
39. Santus P, Radovanovic D, Di Marco F, Raccanelli R, Valenti V, Centanni S. Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study. Pulm Pharmacol Ther 2015; 35: 42-49
40. Barjaktarevic I, Springmeyer S, Gonzalez X, Sirokman W, Coxson HO, Cooper CB. Diffusing capacity for carbon monoxide correlates best with tissue volume from quantitative CT scanning analysis. Chest 2015; 147: 1485-1493
41. Rossi A, Aisanov Z, Avdeev S, Di Maria G, Donner CF, Izquierdo JL, Roche N, Similowski T, Watz H, Worth H, Miravitlles M. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 2015; 109: 785e802
42. Pare PD, Mitzner W. Airway-parenchymal interdependence. Compr Physiol 2012; 2: 1921-1935
43. Ma B, Breen B, Bates JH. Influence of parenchymal heterogeneity on airway-parenchymal interdependence. Respir Physiol Neurobiol 2013; 188: 94-101
44. Weibel ER. Functional morphology of lung parenchyma; in American Physiological Society (ed), Fishman AP, Macklem PT, Mead J, Geiger SR (curators): Handbook of Physiology, Section III: The Respiratory System, vol 3: Mechanics of Breathing; Part I. Morphology of Lung Parenchyma. Bethesda, American Physiological Society, 1986, pp 89-111
45. Weibel ER. The Pathway for Oxygen. Structure and Function of the Mammalian Respiratory System. Cambridge, Harvard University Press, 1984
46. Santus P, Radovanovic D, Di Marco S, Valenti V, Raccanelli R, Blasi F, Centanni S, Bussotti M. Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial. Int J Chron Obstruct Pulmon Dis 2015; 10: 1917-1923
47. Chen R, Lin L, Tian JW, Zeng B, Zhang L, Chen X, Yan HY. Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients. J Thorac Dis 2015; 7: 1142-1150
48. O'Donnell D. Breathlessness in patients with severe chronic airflow limitation. physiologic correlations. Chest 1992; 102: 824-831
49. Satta A, Migliori GB, Spanevello A, Neri M, Bottinelli R, Canepari M, Pellegrino MA, Reggiani C. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10: 2853-2860
50. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in rehabilitation. Eur Respir J 2006; 27: 788-794
51. Burtin C, Saey D, Saglam M, Langer D, Gosselink R, Janssens W, Decramer M, Maltais F, Troosters T. Effectiveness of exercise training in patients with COPD: the role of muscle fatigue. Eur Respir J 2012; 40: 338-344